*GlaxoSmithkline Consumer Healthcare* disclosed a steady growth in standalone net profit for the quarter ended December 2008 due to better sales volume and good operating margins.
During the quarter, the profit of the company rose 18.47% to Rs 325.80 million from Rs 275 million in the same quarter last year. Net sales for the quarter rose 20.93% to Rs 3,435.60 million, while total income for the quarter rose 18.55% to Rs 3,575.60 million, when compared with the prior year period. The company posted earnings of Rs 7.75 a share during the quarter, registering 18.50% growth over prior year period. *Quarterly Results - Standalone (Rs in mn)* *As at* *Dec - 08* *Dec - 07* *%Change* *Net Sales* 3,435.60 2,841.00 20.93 *Net Profit* 325.80 275.00 18.47 *Basic EPS* 7.75 6.54 18.50 During the quarter, the operating margin of the company increased by 217.72 basis points to 14.67% compared with the previous year period. Interest cost increased 2.52 times to Rs 30.30 million while depreciation cost rose 0.57% to Rs 106.60 million over previous year period. The board of directors at its meeting held on Jan. 27, 2009, recommended a final dividend at the rate of Rs 5 a equity share of Rs 10 each. --~--~---------~--~----~------------~-------~--~----~ You received this message because you are subscribed to the Google Groups "Kences1" group. To post to this group, send email to [email protected] To unsubscribe from this group, send email to [email protected] For more options, visit this group at http://groups.google.com/group/kences1?hl=en -~----------~----~----~----~------~----~------~--~---
